Table 1.
MIC breakpoints for Pseudomonas aeruginosa according to EUCAST and CLSI guidelines.
Abbreviations: CLSI: Clinical and Laboratory Standards Institute; EUCAST: European Committee on Antimicrobial Susceptibility Testing; MIC: minimum inhibitory concentration.
Table 2.
Comparison of demographic data, length of hospitalization, and laboratory tests between patients with community-acquired and nosocomial-acquired pneumonia due to Pseudomonas aeruginosa.
Abbreviations: CRP: C-reactive protein; SD: standard deviation.
Table 3.
Drug sensitivity and drug resistance in different drug groups of patients with community-acquired compared to nosocomial-acquired pneumonia caused by Pseudomonas aeruginosa with MIC50 and MIC90 breakpoints of each antibiotic.
Abbreviation: CAP: community-acquired pneumonia; NAP: nosocomial-acquired pneumonia; MIC: minimum inhibitory concentration. Note: Significant P values are shown in bold.
Fig 1.
Rate of development of antibiotic resistance over time for pneumonia due to Pseudomonas aeruginosa from 2004 to 2014.
Table 4.
The various detection methods used and species of Pseudomonas aeruginosa in patients with community-acquired and nosocomial-acquired pneumonia.
Note: Significant P values are shown in bold.
Table 5.
Acute and chronic comorbidities in patients with community-acquired compared to nosocomial-acquired pneumonia caused by Pseudomonas aeruginosa.
Comorbidities were only considered if they were more than 10% in one of the groups, even if they were less than 10% in the other group. Note: Significant P values are shown in bold.
Table 6.
Comparison of demographic data, length of hospitalization, laboratory tests, specimens, and acute and chronic comorbidities between patients with community-acquired and nosocomial-acquired pneumonia due to multidrug-resistant Pseudomonas aeruginosa.
Abbreviations: CAP: community-acquired pneumonia; NAP: nosocomial-acquired pneumonia; SD: standard deviation.
Table 7.
Drug sensitivity and drug resistance in different drug groups of patients with community-acquired compared to nosocomial-acquired pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Abbreviations: CAP: community-acquired pneumonia; NAP: nosocomial-acquired pneumonia; MDR Pseudomonas: multidrug resistant Pseudomonas. Note: Significant P values are shown in bold.